Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROspective PioglitAzone Clinical Trial In MacroVascular Events: A Macrovascular Outcome Study in Type 2 Diabetic Patients Comparing Pioglitazone With Placebo in Addition to Existing Therapy

NCT00174993 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00174993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROspective PioglitAzone Clinical Trial In MacroVascular Events: A Macrovascular Outcome Study in Type 2 Diabetic Patients Comparing Pioglitazone With Placebo in Addition to Existing Therapy
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2001
Completion date
January 31, 2005
Enrollment
4,373 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus